CEO Glen Illing speaks to Milltrust on stem cells genomic sequencing
Roslin Technologies CEO Glen Illing today gave an interview to Milltrust International Group, one of our investors and a key partner in building our business, about what makes our company special and how we are tackling some of the most pressing issues in the world today.
Glen focused on some of the main outcomes of the solutions that we are working on at present including: • the work we do with animal stem cells and how this can be beneficial for drug development and reducing the number of animals needed in research • how we can help cut the use of drugs in agriculture by investing in studies that define animals that are resistant to infectious diseases.
As a company focused on turning cutting-edge science into solutions for the market, it’s always good to have the opportunity to talk about how our services are able to help the food production sector. More information on the applications of the work that we do can be found in our case studies, while the interview can be found here.